SCHEMBL4871867

SCHEMBL4871867

CCc1cccc(-c2nn3ccccc3c2-c2ccc(O)cc2)n1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 14/20 0.53
CCNE1 P24864 1/20 0.53
CDK2 P24941 1/20 0.53
MAPK14 Q16539 3/20 0.42
EGFR P00533 1/20 0.42
RAF1 P04049 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
GSK3B P49841 1/20 0.42
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
THRB P10828 3/20 0.39
AKT1 P31749 1/20 0.38
MYC P01106 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868403 0.88 MAPK14 (0.56) TGFBR1CCNE1CDK2MAPK14EGFR
SCHEMBL4865400 0.86 TGFBR1 (0.55) TGFBR1CCNE1CDK2MAPK14EGFR
SCHEMBL4872159 0.84 TGFBR1 (0.55) TGFBR1MAPK14EGFRRAF1ADORA3
SCHEMBL4874358 0.80 MAPK14 (0.54) TGFBR1CCNE1CDK2MAPK14EGFR
SCHEMBL5233087 0.78 TGFBR1 (0.45) TGFBR1CCNE1CDK2MAPK14EGFR
SCHEMBL4870854 0.76 TGFBR1 (0.43) TGFBR1CCNE1CDK2MAPK14EGFR
SCHEMBL5232302 0.76 EGFR (0.46) TGFBR1CCNE1CDK2EGFRADORA2A
SCHEMBL411190 0.75 TGFBR1 (0.62) TGFBR1MAPK14THRB
SCHEMBL4862130 0.74 TGFBR1 (0.53) TGFBR1MAPK14EGFRRAF1ADORA3
SCHEMBL4873701 0.74 AKT1 (0.46) TGFBR1MAPK14EGFRRAF1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365066-B2 Pyrazolopyridine derivatives as pharmaceutical agents ELI LILLY AND COMPANY (US) 2008-04-29 US claimed
EP-1543001-B1 PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER LILLY CO ELI (US) 2007-08-15 EP disclosed